1. Jager, A.K., K. Krydsfeldt, and H.B. Rasmussen, Bioassay-guided isolation of apigenin with GABA-benzodiazepine activity from Tanacetum parthenium. Phytother Res, 2009.
  2. Johnson, E.S., et al., Efficacy of feverfew as prophylactic treatment of migraine. Br Med J (Clin Res Ed), 1985. 291(6495): p. 569-73.
  3. De Weerdt CJ, Bootsma HPR, and H. H, Herbal medicines in migraine prevention: randomized double-blind placebo-controlled crossover trial of feverfew preparation. Phytomoedicine, 1996. 3: p. 225-230.
  4. Vogler, B.K., M.H. Pittler, and E. Ernst, Feverfew as a preventive treatment for migraine: a systematic review. Cephalalgia, 1998. 18(10): p. 704-8.
  5. Pfaffenrath, V., et al., The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia, 2002. 22(7): p. 523-32.
  6. Diener, H.C., et al., Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia, 2005. 25(11): p. 1031-41.
  7. Lipton, R.B., et al., Petasites hybridus root (butterbur) is an effective preventive treatment for migraine. Neurology, 2004. 63(12): p. 2240-4.
  8. Pothmann, R. and U. Danesch, Migraine prevention in children and adolescents: results of an open study with a special butterbur root extract. Headache, 2005. 45(3): p. 196-203.
  9. McCarty, M.F., Fish oil and other nutritional adjuvants for treatment of congestive heart failure. Med Hypotheses, 1996. 46(4): p. 400-6.
  10. Bianchi, A., et al., Role of magnesium, coenzyme Q10, riboflavin, and vitamin B12 in migraine prophylaxis. Vitam Horm, 2004. 69: p. 297-312.
  11. Ramadan, N.M., et al., Low brain magnesium in migraine. Headache, 1989. 29(9): p. 590-3.
  12. Trauninger, A., et al., Oral magnesium load test in patients with migraine. Headache, 2002. 42(2): p. 114-9.
  13. Mauskop, A. and B.M. Altura, Role of magnesium in the pathogenesis and treatment of migraines. Clin Neurosci, 1998. 5(1): p. 24-7.
  14. Boon, H. and J. Wong, Botanical medicine and cancer: a review of the safety and efficacy. Expert Opin Pharmacother, 2004. 5(12): p. 2485-501.
  15. Willetts, K.E., A. Ekangaki, and J.A. Eden, Effect of a ginger extract on pregnancy-induced nausea: a randomised controlled trial. Aust N Z J Obstet Gynaecol, 2003. 43(2): p. 139-44.
  16. Schwertner, H.A., D.C. Rios, and J.E. Pascoe, Variation in concentration and labeling of ginger root dietary supplements. Obstet Gynecol, 2006. 107(6): p. 1337-43.
  17. Sewell, R.A., Response of cluster headache to kudzu. Headache, 2009. 49(1): p. 98-105.
  18. Yamazaki, T., et al., Pharmacological studies on Puerariae Flos. IV: Effects of Pueraria thomsonii dried flower extracts on blood ethanol and acetaldehyde levels in humans. Int J Clin Pharmacol Res, 2002. 22(1): p. 23-8.
  19. Schoenen, J., J. Jacquy, and M. Lenaerts, Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology, 1998. 50(2): p. 466-70.
  20. Rozen, T.D., et al., Open label trial of coenzyme Q10 as a migraine preventive. Cephalalgia, 2002. 22(2): p. 137-41.
  21. Sandor, P.S., et al., Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology, 2005. 64(4): p. 713-5.